CHARLES

CHARLES is a healthcare technology company that specializes in offering online medical consultations, allowing users to access personalized medical advice through a digital platform. Founded in 2018 and headquartered in Paris, France, CHARLES offers a platform for online medical consultations. The company was established by Andreas Tussing and Artjem Weissbeck. In May 2022, CHARLES raised EUR 4 million in Seed funding from Kurma Partners and Speedinvest, bringing the total amount raised to EUR 4 million with a current valuation of EUR 18.

708 million. CHARLES provides online medical consultation services, addressing health concerns such as musculoskeletal disorders, hormonal imbalances, sexual health, sleep disturbances, and fertility issues. The platform connects patients with licensed medical professionals for personalized diagnoses and tailored treatment plans, allowing for immediate access to medical expertise without in-person visits. Their target clientele includes adults seeking convenient healthcare solutions, primarily operating within the French market.

In the most recent year, CHARLES reported a revenue of EUR 1,030,971. The company utilizes a subscription-based revenue model, enabling clients to access ongoing medical consultation services. Clients pay a set fee for comprehensive consultations, with options for specialized treatment plans, catering to both B2B partnerships and direct-to-consumer transactions. Following a successful Seed funding round in May 2022, CHARLES plans to use the EUR 4 million raised to expand its service offerings and enhance its team.

The company is actively looking to introduce new products, although specific details and release dates have not been provided. Additionally, CHARLES aims to explore expansion into new markets, with targeted regions to be determined in upcoming strategic initiatives.